Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NVCR
|
William F Doyle
Executive Chairman |
SELL
Open market or private sale
|
Direct | 2,385 Reduced 0.43% |
$167,188
$70.1 p/Share
|
Mar 08
2022 |
|
NVCR
|
Todd Christopher Longsworth
General Counsel |
SELL
Open market or private sale
|
Direct | 2,339 Reduced 3.61% |
$163,964
$70.1 p/Share
|
Mar 08
2022 |
|
NVCR
|
Ashley Cordova
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 759 Reduced 1.23% |
$53,206
$70.1 p/Share
|
Mar 08
2022 |
|
NVCR
|
Wilhelmus Cm Groenhuysen
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,923 Reduced 1.74% |
$204,902
$70.1 p/Share
|
Mar 08
2022 |
|
NVCR
|
William Patrick Burke
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 1,037 Reduced 1.82% |
$72,694
$70.1 p/Share
|
Mar 08
2022 |
|
NVCR
|
Frank X Leonard
EVP, Pres., Novocure Oncology |
SELL
Open market or private sale
|
Direct | 744 Reduced 0.72% |
$52,154
$70.1 p/Share
|
Mar 08
2022 |
|
CZR
|
Michael E Pegram
Director |
BUY
Open market or private purchase
|
Indirect | 13,000 Added 13.31% |
$895,570
$68.89 p/Share
|
Mar 08
2022 |
|
RGEN
|
Jon Snodgres
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,166 Added 9.45% |
$194,552
$46.7 p/Share
|
Mar 08
2022 |
|
OVV
|
Steven W Nance
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,184 Added 19.35% |
-
|
Mar 08
2022 |
|
OVV
|
Thomas G Ricks
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,184 Added 8.35% |
-
|
Mar 08
2022 |
|
BILL
|
Rene A. Lacerte
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 19,011 Added 19.4% |
$99,998
$5.26 p/Share
|
Mar 08
2022 |
|
NET
|
Matthew Prince
CEO & Board Co-Chair |
SELL
Open market or private sale
|
Indirect | 52,384 Reduced 58.49% |
$4,884,284
$93.24 p/Share
|
Mar 08
2022 |
|
NET
|
Matthew Prince
CEO & Board Co-Chair |
BUY
Conversion of derivative security
|
Indirect | 52,384 Added 50.0% |
-
|
Mar 08
2022 |
|
GRMN
|
Jonathan Burrell
Director |
SELL
Bona fide gift
|
Indirect | 700,000 Reduced 7.89% |
-
|
Mar 08
2022 |
|
GRMN
|
Jonathan Burrell
Director |
BUY
Bona fide gift
|
Indirect | 700,000 Added 25.84% |
-
|
Mar 08
2022 |
|
VRSN
|
Thomas C Indelicarto
EVP, Gen Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 614 Reduced 1.34% |
$131,525
$214.21 p/Share
|
Mar 08
2022 |
|
VICI
|
Michael D Rumbolz
Director |
BUY
Open market or private purchase
|
Indirect | 1,725 Added 50.0% |
$46,385
$26.89 p/Share
|
Mar 08
2022 |
|
VICI
|
Michael D Rumbolz
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 3.21% |
$53,760
$26.88 p/Share
|
Mar 08
2022 |
|
VTR
|
Gregory R Liebbe
SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 429 Reduced 2.25% |
$24,822
$57.86 p/Share
|
Mar 08
2022 |
|
ABC
|
Steven H Collis
Executive Chairman |
SELL
Open market or private sale
|
Direct | 11,480 Reduced 5.3% |
$1,664,256
$144.97 p/Share
|
Mar 08
2022 |
|
ABC
|
Steven H Collis
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 11,480 Added 5.03% |
$868,003
$75.61 p/Share
|
Mar 08
2022 |
|
HLT
|
Michael W Duffy
Officer |
SELL
Open market or private sale
|
Direct | 4,800 Reduced 15.56% |
$656,304
$136.73 p/Share
|
Mar 08
2022 |
|
KR
|
Stuart Aitken
Senior Vice President |
SELL
Open market or private sale
|
Direct | 57,154 Reduced 24.35% |
$3,246,347
$56.8 p/Share
|
Mar 08
2022 |
|
KR
|
Stuart Aitken
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 57,154 Added 19.58% |
$2,166,708
$37.91 p/Share
|
Mar 08
2022 |
|
KR
|
Calvin J Kaufman
Senior Vice President |
SELL
Open market or private sale
|
Direct | 46,568 Reduced 23.64% |
$2,707,463
$58.14 p/Share
|
Mar 08
2022 |
|
KR
|
Calvin J Kaufman
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 46,568 Added 19.12% |
$1,466,892
$31.5 p/Share
|
Mar 08
2022 |
|
MSI
|
Daniel G Pekofske
CVP and CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 185 Reduced 5.74% |
$39,614
$214.13 p/Share
|
Mar 08
2022 |
|
MSI
|
Mahesh Saptharishi
EVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct | 245 Reduced 1.87% |
$52,462
$214.13 p/Share
|
Mar 08
2022 |
|
ADSK
|
Deborah Clifford
EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,073 Reduced 17.94% |
$810,894
$199.09 p/Share
|
Mar 08
2022 |
|
ETN
|
Joao V Faria
Officer |
SELL
Open market or private sale
|
Direct | 11,852 Reduced 14.86% |
$1,777,800
$150.0 p/Share
|
Mar 08
2022 |
|
ETN
|
Joao V Faria
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 11,852 Added 13.81% |
$1,058,976
$89.35 p/Share
|
Mar 08
2022 |
|
EQIX
|
Peter Van Camp
Executive Chairman |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 12.3% |
$687,340
$687.34 p/Share
|
Mar 08
2022 |
|
RCG
|
Murray Stahl
President |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.2% |
$1,607
$2.38 p/Share
|
Mar 08
2022 |
|
ASB
|
Karen Van Lith
Director |
SELL
Open market or private sale
|
Direct | 4,500 Reduced 7.38% |
$102,870
$22.86 p/Share
|
Mar 08
2022 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.19% |
$3,856
$1285.42 p/Share
|
Mar 08
2022 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 27 Added 0.07% |
$34,706
$1285.42 p/Share
|
Mar 08
2022 |
|
GL
|
Robert Brian Mitchell
EVP, General Counsel and CRO |
BUY
Bona fide gift
|
Indirect | 2,372 Added 4.17% |
-
|
Mar 08
2022 |
|
GL
|
Robert Brian Mitchell
EVP, General Counsel and CRO |
SELL
Bona fide gift
|
Direct | 2,372 Reduced 100.0% |
-
|
Mar 08
2022 |
|
SNEX
|
Diego Rotsztain
Chief Governance/Legal Officer |
BUY
Open market or private purchase
|
Direct | 750 Added 8.25% |
$49,680
$66.24 p/Share
|
Mar 08
2022 |
|
NEE
|
James Michael May
VP, Controller and CAO |
SELL
Open market or private sale
|
Direct | 4,321 Reduced 41.82% |
$367,285
$85.0 p/Share
|
Mar 08
2022 |
|
PG
|
Bertrand Marc Allen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 171 Added 6.77% |
-
|
Mar 08
2022 |
|
PG
|
Angela F Braly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 205 Added 0.41% |
-
|
Mar 08
2022 |
|
PG
|
Joseph Jimenez
Director |
BUY
Grant, award, or other acquisition
|
Direct | 239 Added 0.98% |
-
|
Mar 08
2022 |
|
PG
|
Christopher J Kempczinski
Director |
BUY
Grant, award, or other acquisition
|
Direct | 171 Added 9.68% |
-
|
Mar 08
2022 |
|
PG
|
Terry J Lundgren
Director |
BUY
Grant, award, or other acquisition
|
Direct | 213 Added 0.65% |
-
|
Mar 08
2022 |
|
PG
|
Christine M Mc Carthy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 171 Added 2.51% |
-
|
Mar 08
2022 |
|
PG
|
Patricia A Woertz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 222 Added 0.55% |
-
|
Mar 08
2022 |
|
STEM
|
David S Buzby |
SELL
Open market or private sale
|
Indirect | 86,121 Reduced 96.03% |
$775,950
$9.01 p/Share
|
Mar 08
2022 |
|
IRDM
|
Steven B Pfeiffer
Director |
SELL
Open market or private sale
|
Direct | 3,002 Reduced 2.62% |
$118,879
$39.6 p/Share
|
Mar 08
2022 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,300 Reduced 0.01% |
$445,694
$193.78 p/Share
|
Mar 08
2022 |